HomeNDC LookupRxCUI directory › RxCUI 581417

Psyllium 520 MG Oral Capsule — RxCUI 581417

RxNorm drug concept · Semantic clinical drug
RxCUI 581417 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 10 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI581417
Official namePsyllium 520 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspsyllium 0.52 GM Oral Capsule
FDA products mapped10
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Psyllium: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Psyllium is a fiber laxative used to treat occasional constipation and help you get back to a regular routine. It comes in capsules and oral powders under several brand names. Most...
  • Yes, this one is really important. Always mix the powder into a full 8-ounce glass of water or another liquid, stir it well, and drink it right away before it thickens up. If you s...
  • How do I take the powder correctly? I've heard there's a choking risk.
  • It can, yes. Psyllium can slow down how your body absorbs medicines you take by mouth, which may make them less effective. The simple fix: take any prescription medicine at least 2...
📖 Read our full Psyllium guide →

🕸️ Concept Web — How Psyllium 520 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Psyllium 520 MG Oral Capsule RxCUI 581417

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Psyllium 8928
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Wal-Mucil 1087164
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Psyllium Oral Capsule 204593
    • Psyllium Oral Product 1163578
    • Psyllium Pill 1163579
    • Psyllium Oral Capsule [Wal-Mucil] 1100911
    • Wal-Mucil Oral Product 1187780
    • Wal-Mucil Pill 1187781
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Psyllium 520 MG 581416
    • Psyllium 520 MG Oral Capsule [Wal-Mucil] 1100912
    • Psyllium 520 MG [Wal-Mucil] 1100910

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Psyllium 520 MG SCDC · 581416
  • Psyllium Oral Capsule SCDF · 204593
  • Psyllium Oral Product SCDG · 1163578
  • Psyllium Pill SCDG · 1163579

Brand-Name Concepts

  • Psyllium 520 MG Oral Capsule [Wal-Mucil] SBD · 1100912
  • Psyllium 520 MG [Wal-Mucil] SBDC · 1100910
  • Psyllium Oral Capsule [Wal-Mucil] SBDF · 1100911
  • Wal-Mucil Oral Product SBDG · 1187780
  • Wal-Mucil Pill SBDG · 1187781
  • Wal-Mucil BN · 1087164

📦 FDA Products & Package NDCs

10 products · 10 package NDCs
10 package NDCs map to RxCUI 581417 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
11673-0509-87 160 CAPSULE in 1 BOTTLE (11673-509-87) Target Fiber Laxative TARGET CORPORATION 2019-04-16
41250-0230-32 320 CAPSULE in 1 BOTTLE (41250-230-32) meijer fiber laxative MEIJER DISTRIBUTION, INC 2017-03-14
41250-0610-16 160 CAPSULE in 1 BOTTLE (41250-610-16) meijer fiber laxative MEIJER DISTRIBUTION, INC 2017-03-07
41415-0119-60 160 CAPSULE in 1 BOTTLE (41415-119-60) PUBLIX PUBLIX SUPER MARKETS, INC 2019-05-21
41520-0907-60 160 CAPSULE in 1 BOTTLE (41520-907-60) CAREONE FOODHOLD USA 2019-04-16
63868-0348-01 160 CAPSULE in 1 BOTTLE (63868-348-01) Quality Choice Fiber Laxative QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) 2019-04-18
63941-0119-10 100 CAPSULE in 1 BOTTLE (63941-119-10) Best Choice Fiber Laxative BEST CHOICE (VALU MERCHANDISERS COMPANY) 2019-05-16
68016-0649-00 100 CAPSULE in 1 BOTTLE (68016-649-00) Premier Value Fiber Chain Drug Consortium, LLC 2011-07-01
68163-0119-25 25 CAPSULE in 1 BOTTLE (68163-119-25) fiber laxative Raritan Pharmaceuticals Inc 2019-04-16
68196-0119-40 400 CAPSULE in 1 BOTTLE (68196-119-40) SAMS WEST SAM'S WEST INC 2019-05-21
Observed labelers: MEIJER DISTRIBUTION, INC (2) · BEST CHOICE (VALU MERCHANDISERS COMPANY) (1) · Chain Drug Consortium, LLC (1) · FOODHOLD USA (1) · PUBLIX SUPER MARKETS, INC (1) · QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.